Bank of America’s CureVac CVAC Stock Holding History

Bank of America’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44,700	Closed	-$188K	–	7809
2023 Q4	$188K	Buy	+44,700	New	+$242K	﹤0.01%	6098
2021 Q3	–	Sell	-25,000	Closed	-$1.84M	–	8145
2021 Q2	$1.84M	Buy	+25,000	New	+$2.5M	﹤0.01%	4397

Bank of America's CVAC Position: Q1 2026 in Review

Bank of America sold out of CureVac (CVAC) in Q1 2026, closing a stake of 548,367 shares — an estimated $2.48M sold.

Bank of America first reported a position in CVAC in Q3 2020 and held it in 22 quarters. The position peaked at $2.5M in Q4 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Bank of America reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Bank of America sold 548,367 CureVac shares in Q1 2026, an estimated $2.48M.
Bank of America first reported a position in CureVac in Q3 2020 and held it in 22 quarters.
Bank of America's CureVac position peaked at $2.5M in Q4 2021.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.